METYRAPONE

METYRAPONE was reported 999 times

METYRAPONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 11-DEOXYCORTICOSTERONE INCREASED 1 0.3333
1 PLATELET DISTRIBUTION WIDTH ABNORMAL 3 0.2727
2 CORTISOL FREE URINE INCREASED 14 0.2090
3 SMALL CELL CARCINOMA OF THE CERVIX 1 0.1667
4 ACTH-PRODUCING PITUITARY TUMOUR 2 0.1538
5 MONOCYTE PERCENTAGE ABNORMAL 3 0.1364
6 BLOOD CORTICOSTERONE INCREASED 1 0.1000
7 ECTOPIC ACTH SYNDROME 4 0.0678
8 ADRENAL ATROPHY 4 0.0645
9 NEUTROPHIL PERCENTAGE ABNORMAL 3 0.0600
10 ULTRASOUND UTERUS ABNORMAL 3 0.0566
11 HYPERCORTICOIDISM 5 0.0472
12 LYMPHOCYTE PERCENTAGE ABNORMAL 3 0.0435
13 ADRENAL CARCINOMA 2 0.0426
14 ADRENALECTOMY 4 0.0408
15 CORTISOL INCREASED 25 0.0400
16 BLOOD CORTICOTROPHIN INCREASED 10 0.0346
17 NEONATAL HYPONATRAEMIA 4 0.0328
18 HYPERADRENOCORTICISM 9 0.0327
19 LEGIONELLA TEST POSITIVE 1 0.0323
20 HYPERPLASIA ADRENAL 2 0.0317
21 PITUITARY TUMOUR REMOVAL 3 0.0316
22 ADRENAL CORTICAL INSUFFICIENCY 1 0.0303
23 GLUCOCORTICOID DEFICIENCY 12 0.0284
24 PITUITARY INFARCTION 1 0.0233
25 BLOOD CORTISOL INCREASED 5 0.0189
26 SMALL CELL LUNG CANCER RECURRENT 1 0.0175
27 BRONCHOALVEOLAR LAVAGE 1 0.0164
28 RED CELL DISTRIBUTION WIDTH ABNORMAL 3 0.0158
29 PITUITARY-DEPENDENT CUSHING'S SYNDROME 1 0.0152
30 ADRENAL GLAND CANCER METASTATIC 1 0.0147
31 BLOOD CORTICOTROPHIN DECREASED 7 0.0143
32 MONOCYTE COUNT ABNORMAL 3 0.0135
33 OVARIAN GRANULOSA CELL TUMOUR 1 0.0133
34 CARCINOID CRISIS 3 0.0133
35 HIGH DENSITY LIPOPROTEIN ABNORMAL 3 0.0128
36 PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC 3 0.0126
37 BLOOD CORTISOL ABNORMAL 1 0.0125
38 PREMATURE BABY DEATH 1 0.0122
39 ULTRASOUND FOETAL ABNORMAL 1 0.0119
40 BLOOD ALDOSTERONE INCREASED 2 0.0114
41 ADRENOCORTICAL CARCINOMA 1 0.0114
42 RED BLOOD CELL NUCLEATED MORPHOLOGY PRESENT 1 0.0110
43 HYPERANDROGENISM 1 0.0106
44 MYCOTIC ENDOPHTHALMITIS 2 0.0106
45 CORTISOL ABNORMAL 2 0.0101
46 BLOOD BICARBONATE ABNORMAL 1 0.0089
47 SUBDIAPHRAGMATIC ABSCESS 1 0.0089
48 PROSTATIC MASS 1 0.0085
49 CARCINOID TUMOUR PULMONARY 2 0.0083
50 HYPERADRENALISM 1 0.0082
51 CORTISOL DECREASED 9 0.0079
52 BLOOD GASTRIN INCREASED 1 0.0078
53 LEUKOSTASIS SYNDROME 1 0.0075
54 PLATELET AGGREGATION ABNORMAL 1 0.0066
55 PITUITARY HAEMORRHAGE 2 0.0065
56 THERAPEUTIC EMBOLISATION 2 0.0064
57 MEAN CELL VOLUME ABNORMAL 3 0.0064
58 BLOOD CORTISOL DECREASED 4 0.0063
59 HAEMODIALYSIS COMPLICATION 1 0.0059
60 BLOOD LACTIC ACID DECREASED 1 0.0058
61 EPIDURAL LIPOMATOSIS 2 0.0058
62 PERIPARTUM CARDIOMYOPATHY 1 0.0058
63 ADRENOCORTICAL INSUFFICIENCY ACUTE 11 0.0056
64 PREMATURE RUPTURE OF MEMBRANES 13 0.0054
65 HEPATIC INFARCTION 2 0.0053
66 EMPHYSEMATOUS CYSTITIS 1 0.0047
67 SEVERE ACUTE RESPIRATORY SYNDROME 1 0.0045
68 BLOOD LACTATE DEHYDROGENASE ABNORMAL 3 0.0044
69 FOETAL HEART RATE DECELERATION 1 0.0043
70 PANCREATIC CARCINOMA RECURRENT 1 0.0041
71 METASTASES TO GASTROINTESTINAL TRACT 1 0.0041
72 ENTEROBACTER TEST POSITIVE 1 0.0041
73 HEMIANOPIA 4 0.0040
74 ADRENAL INSUFFICIENCY 45 0.0037
75 RENIN INCREASED 1 0.0037
76 HAEMORRHAGIC INFARCTION 2 0.0036
77 PULMONARY NOCARDIOSIS 3 0.0036
78 PNEUMOCYSTIS JIROVECII PNEUMONIA 35 0.0035
79 PRIMARY ADRENAL INSUFFICIENCY 1 0.0033
80 BLOOD BETA-D-GLUCAN INCREASED 1 0.0033
81 TRANSFUSION-RELATED ACUTE LUNG INJURY 1 0.0032
82 HEPATECTOMY 1 0.0032
83 PNEUMOCYSTIS JIROVECI PNEUMONIA 7 0.0031
84 RED BLOOD CELL ABNORMALITY 3 0.0031
85 EYE INFECTION VIRAL 1 0.0031
86 IMMUNE-MEDIATED HEPATITIS 6 0.0029
87 ADMINISTRATION SITE BRUISE 1 0.0029
88 TACHYPHYLAXIS 1 0.0029
89 SMALL CELL LUNG CANCER METASTATIC 1 0.0028
90 NEONATAL ASPHYXIA 2 0.0028
91 PRE-ECLAMPSIA 13 0.0027
92 SMALL CELL LUNG CANCER STAGE UNSPECIFIED 1 0.0027
93 DISSEMINATED CRYPTOCOCCOSIS 2 0.0026
94 EYE INFECTION FUNGAL 1 0.0026
95 PNEUMONIA CYTOMEGALOVIRAL 5 0.0026
96 ADRENAL GLAND CANCER 1 0.0026
97 FOETAL GROWTH RETARDATION 2 0.0026
98 TRACHEOMALACIA 1 0.0025
99 FACTOR V LEIDEN MUTATION 1 0.0025
100 HAPTOGLOBIN DECREASED 2 0.0025
101 HYPOGLYCAEMIA NEONATAL 4 0.0025
102 PITUITARY TUMOUR BENIGN 4 0.0025
103 METASTASES TO SPLEEN 1 0.0024
104 ADRENAL SUPPRESSION 2 0.0024
105 HIRSUTISM 3 0.0023
106 PUPILLARY REFLEX IMPAIRED 4 0.0022
107 ADRENAL NEOPLASM 1 0.0021
108 PATIENT UNCOOPERATIVE 1 0.0021
109 OPEN FRACTURE 1 0.0021
110 ABDOMINAL WALL HAEMATOMA 4 0.0020
111 SKIN STRIAE 3 0.0020
112 PITUITARY TUMOUR 3 0.0020
113 METASTASES TO BONE MARROW 1 0.0020
114 SECONDARY ADRENOCORTICAL INSUFFICIENCY 3 0.0020
115 DYSPNOEA EXACERBATED 1 0.0019
116 PHYSICAL DECONDITIONING 5 0.0019
117 PROCEDURAL SITE REACTION 1 0.0019
118 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 2 0.0018
119 PANCREATECTOMY 1 0.0018
120 LEGIONELLA INFECTION 1 0.0017
121 PO2 DECREASED 2 0.0017
122 HEPATORENAL FAILURE 1 0.0017
123 LOW BIRTH WEIGHT BABY 13 0.0016
124 PREMATURE DELIVERY 26 0.0016
125 MEDICAL DEVICE SITE INFECTION 1 0.0016
126 LIPOHYPERTROPHY 1 0.0016
127 PANCREATIC NEUROENDOCRINE TUMOUR 1 0.0016
128 CUSHINGOID 5 0.0016
129 BLOOD POTASSIUM ABNORMAL 4 0.0015
130 AREFLEXIA 4 0.0015
131 COMPUTERISED TOMOGRAM THORAX ABNORMAL 1 0.0015
132 CUSHING'S SYNDROME 1 0.0014
133 FOETAL HEART RATE DECELERATION ABNORMALITY 1 0.0014
134 ATYPICAL MYCOBACTERIAL INFECTION 2 0.0014
135 BLOOD TESTOSTERONE INCREASED 3 0.0014
136 THROMBOTIC STROKE 1 0.0014
137 CENTRAL OBESITY 1 0.0014
138 PLACENTAL INSUFFICIENCY 1 0.0012
139 INTERVERTEBRAL DISC SPACE NARROWING 1 0.0012
140 RESPIRATORY ALKALOSIS 2 0.0012
141 GLOMERULAR FILTRATION RATE INCREASED 1 0.0012
142 INFECTED BITE 1 0.0012
143 HEPATIC CANCER METASTATIC 1 0.0012
144 HYPERAMMONAEMIC ENCEPHALOPATHY 2 0.0011
145 FOOD REFUSAL 1 0.0011
146 NEONATAL RESPIRATORY DISTRESS SYNDROME 4 0.0011
147 UPPER AIRWAY OBSTRUCTION 1 0.0011
148 NASAL CAVITY CANCER 1 0.0011
149 METASTASES TO ADRENALS 1 0.0011
150 FOETAL HEART RATE ABNORMAL 1 0.0011
151 BIOPSY 1 0.0011
152 HYPERTRICHOSIS 2 0.0011
153 HEPATIC ENCEPHALOPATHY 10 0.0011
154 NEUTROPHIL COUNT ABNORMAL 3 0.0011
155 PLACENTAL DISORDER 1 0.0011
156 GESTATIONAL DIABETES 5 0.0010
157 CANCER SURGERY 1 0.0010
158 ADRENAL DISORDER 2 0.0010
159 PCO2 DECREASED 1 0.0010
160 ONCOLOGIC COMPLICATION 1 0.0010
161 GASTROINTESTINAL NECROSIS 3 0.0010
162 BICYTOPENIA 2 0.0010
163 STEROID WITHDRAWAL SYNDROME 1 0.0010
164 ENTEROCOCCAL BACTERAEMIA 1 0.0009
165 BUNDLE BRANCH BLOCK LEFT 4 0.0009
166 HYPERTENSIVE NEPHROPATHY 1 0.0009
167 TUMOUR PSEUDOPROGRESSION 1 0.0009
168 PNEUMONIA STREPTOCOCCAL 1 0.0009
169 PREMATURE BABY 27 0.0009
170 DIFFUSE ALVEOLAR DAMAGE 1 0.0009
171 SYSTEMIC MYCOSIS 1 0.0009
172 BILIRUBIN CONJUGATED INCREASED 2 0.0009
173 HYPOCHLORAEMIA 1 0.0009
174 PNEUMONIA INFLUENZAL 1 0.0008
175 EMBOLISM ARTERIAL 1 0.0008
176 BLEEDING TIME PROLONGED 1 0.0008
177 SEDATION COMPLICATION 2 0.0008
178 ANGLE CLOSURE GLAUCOMA 2 0.0008
179 APGAR SCORE LOW 1 0.0008
180 TUMOUR PAIN 1 0.0008
181 ANION GAP INCREASED 1 0.0007
182 METASTASES TO LYMPH NODES 5 0.0007
183 ISCHAEMIC HEPATITIS 1 0.0007
184 BILIARY TRACT DISORDER 1 0.0007
185 PERITONEAL HAEMORRHAGE 1 0.0007
186 HYPERGLYCAEMIA 26 0.0007
187 PERIPHERAL ARTERY OCCLUSION 1 0.0007
188 PREMATURE LABOUR 4 0.0007
189 NAIL INFECTION 1 0.0007
190 HEPATIC LESION 3 0.0007
191 PANCREATIC ENZYMES INCREASED 1 0.0007
192 METASTASES TO BONE 11 0.0007
193 MIXED LIVER INJURY 2 0.0007
194 HEPATOCELLULAR INJURY 9 0.0006
195 ACUTE RESPIRATORY DISTRESS SYNDROME 11 0.0006
196 REBOUND EFFECT 7 0.0006
197 CRYPTOCOCCOSIS 1 0.0006
198 PANCREATIC DISORDER 3 0.0006
199 SPLENIC RUPTURE 1 0.0006
200 CARDIAC FAILURE ACUTE 4 0.0006
201 POTENTIATING DRUG INTERACTION 2 0.0006
202 ENTEROBACTER INFECTION 1 0.0006
203 HYPOKALAEMIA 27 0.0006
204 BLOOD AMYLASE INCREASED 1 0.0006
205 EYE MOVEMENT DISORDER 4 0.0006
206 HYPOPITUITARISM 1 0.0006
207 MENINGITIS CRYPTOCOCCAL 1 0.0006
208 DISSEMINATED INTRAVASCULAR COAGULATION 8 0.0006
209 DEPRESSIVE SYMPTOM 2 0.0006
210 GASTROINTESTINAL OEDEMA 1 0.0006
211 INTESTINAL ISCHAEMIA 3 0.0005
212 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
213 OPPORTUNISTIC INFECTION 1 0.0005
214 CATHETER PLACEMENT 1 0.0005
215 BLOOD CHOLESTEROL DECREASED 1 0.0005
216 GRANULOCYTOPENIA 3 0.0005
217 MECHANICAL VENTILATION 1 0.0005
218 OSTEOPOROTIC FRACTURE 1 0.0005
219 THERAPEUTIC PRODUCT EFFECT VARIABLE 2 0.0005
220 HEPATITIS 13 0.0005
221 PNEUMONIA STAPHYLOCOCCAL 1 0.0005
222 EXPOSURE VIA BREAST MILK 2 0.0005
223 HYPOPHYSITIS 1 0.0005
224 SMALL INTESTINAL HAEMORRHAGE 1 0.0005
225 FOETAL GROWTH RESTRICTION 3 0.0005
226 RENAL HAEMORRHAGE 1 0.0005
227 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
228 DIVERTICULAR PERFORATION 1 0.0005
229 SKIN HYPERPIGMENTATION 4 0.0005
230 MUSCLE STRAIN 4 0.0005
231 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
232 NEOPLASM PROGRESSION 16 0.0005
233 NOSOCOMIAL INFECTION 1 0.0005
234 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
235 METASTASES TO MENINGES 1 0.0004
236 OFF LABEL USE 383 0.0004
237 MYOCARDITIS 5 0.0004
238 CYTOMEGALOVIRUS COLITIS 1 0.0004
239 CAESAREAN SECTION 5 0.0004
240 EOSINOPHIL COUNT DECREASED 1 0.0004
241 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
242 EXPOSURE DURING PREGNANCY 26 0.0004
243 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 2 0.0004
244 VASODILATATION 1 0.0004
245 MATERNAL EXPOSURE DURING PREGNANCY 35 0.0004
246 HEPATITIS TOXIC 1 0.0004
247 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
248 TEMPOROMANDIBULAR JOINT SYNDROME 1 0.0004
249 ABDOMINAL MASS 1 0.0004
250 BLOOD SODIUM INCREASED 1 0.0004
251 NORMAL NEWBORN 2 0.0004
252 ASPIRATION 4 0.0004
253 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
254 HYPOGLYCAEMIC COMA 1 0.0003
255 LUNG INFILTRATION 3 0.0003
256 CREPITATIONS 1 0.0003
257 THYROIDITIS 1 0.0003
258 TENSION 2 0.0003
259 CELLULITIS 16 0.0003
260 DRUG EFFECT INCREASED 1 0.0003
261 HEPATOTOXICITY 7 0.0003
262 VENTRICULAR HYPOKINESIA 1 0.0003
263 STUPOR 1 0.0003
264 HEPATITIS ACUTE 2 0.0003
265 BREAST ENLARGEMENT 1 0.0003
266 ASPERGILLUS INFECTION 2 0.0003
267 CYTOLYTIC HEPATITIS 1 0.0003
268 SEPTIC SHOCK 13 0.0003
269 METASTASES TO SPINE 1 0.0003
270 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
271 APPENDICECTOMY 1 0.0003
272 METASTASIS 2 0.0003
273 BONE LESION 1 0.0003
274 ANOSMIA 4 0.0003
275 THROMBOCYTOSIS 1 0.0003
276 PARADOXICAL DRUG REACTION 1 0.0003
277 FOETAL EXPOSURE DURING PREGNANCY 22 0.0003
278 HYPOGLYCAEMIA 13 0.0003
279 HEPATIC NECROSIS 1 0.0003
280 OESOPHAGEAL ULCER 1 0.0003
281 EJECTION FRACTION DECREASED 4 0.0003
282 CARDIOPULMONARY FAILURE 1 0.0003
283 HYPERPHAGIA 1 0.0003
284 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
285 RESPIRATORY FAILURE 18 0.0002
286 BLOOD POTASSIUM INCREASED 4 0.0002
287 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
288 EMBOLISM 2 0.0002
289 CYTOMEGALOVIRUS INFECTION 4 0.0002
290 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
291 AORTIC VALVE INCOMPETENCE 1 0.0002
292 PULMONARY TUBERCULOSIS 1 0.0002
293 PSEUDOMONAS INFECTION 2 0.0002
294 ANOREXIA 3 0.0002
295 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
296 METASTATIC NEOPLASM 1 0.0002
297 HYPERKALAEMIA 8 0.0002
298 METASTASES TO LIVER 4 0.0002
299 MALIGNANT NEOPLASM PROGRESSION 23 0.0002
300 TACHYPNOEA 3 0.0002
301 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
302 IMMUNE THROMBOCYTOPENIA 1 0.0002
303 PNEUMONIA BACTERIAL 2 0.0002
304 OVARIAN CANCER 2 0.0002
305 LOCALISED OEDEMA 1 0.0002
306 PRODUCT DISTRIBUTION ISSUE 2 0.0002
307 HAEMATOTOXICITY 2 0.0002
308 MYELODYSPLASTIC SYNDROME 3 0.0002
309 STILLBIRTH 1 0.0002
310 STAPHYLOCOCCAL SEPSIS 1 0.0002
311 DEEP VEIN THROMBOSIS 13 0.0002
312 CORONARY ARTERY STENOSIS 1 0.0002
313 KLEBSIELLA INFECTION 1 0.0002
314 DYSLIPIDAEMIA 1 0.0002
315 ENDOCARDITIS 1 0.0002
316 FOETAL DEATH 1 0.0002
317 DRUG-INDUCED LIVER INJURY 6 0.0002
318 BLOOD LACTIC ACID INCREASED 1 0.0002
319 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
320 STRESS FRACTURE 1 0.0002
321 BLOOD BILIRUBIN INCREASED 5 0.0002
322 HYDROCEPHALUS 1 0.0002
323 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 10 0.0002
324 LIVER DISORDER 8 0.0002
325 TRANSAMINASES INCREASED 4 0.0002
326 BLOOD CALCIUM DECREASED 2 0.0002
327 MITRAL VALVE INCOMPETENCE 2 0.0002
328 DRUG EXPOSURE DURING PREGNANCY 6 0.0002
329 GENERALISED ERYTHEMA 1 0.0002
330 INTENTIONAL DOSE OMISSION 5 0.0002
331 NEOPLASM 2 0.0002
332 MULTI-ORGAN FAILURE 3 0.0002
333 METASTASES TO LUNG 2 0.0002
334 METABOLIC DISORDER 1 0.0002
335 ELECTROLYTE IMBALANCE 2 0.0002
336 HYPOVOLAEMIA 1 0.0002
337 HYPOXIA 6 0.0002
338 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
339 MYOCLONUS 2 0.0002
340 PROTHROMBIN TIME PROLONGED 1 0.0002
341 POLYNEUROPATHY 2 0.0002
342 HEPATITIS CHOLESTATIC 1 0.0002
343 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
344 HYPERCALCAEMIA 2 0.0002
345 ABNORMAL WEIGHT GAIN 2 0.0002
346 AGRANULOCYTOSIS 3 0.0002
347 HEPATIC ENZYME INCREASED 11 0.0002
348 CHOLANGITIS 1 0.0002
349 THROMBOCYTOPENIA 18 0.0002
350 DISEASE PROGRESSION 19 0.0002
351 LEUKOPENIA 8 0.0002
352 GASTRIC ULCER 3 0.0002
353 HEPATIC CYTOLYSIS 2 0.0002
354 CHOLESTASIS 3 0.0002
355 THERAPY NON-RESPONDER 7 0.0002
356 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
357 CORONAVIRUS INFECTION 1 0.0002
358 MENINGITIS 1 0.0001
359 PRODUCT TASTE ABNORMAL 2 0.0001
360 OEDEMA PERIPHERAL 18 0.0001
361 ANAEMIA 28 0.0001
362 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
363 ENCEPHALITIS 1 0.0001
364 MENTAL STATUS CHANGES 4 0.0001
365 HYPERTRANSAMINASAEMIA 1 0.0001
366 HYPOMAGNESAEMIA 2 0.0001
367 LYMPHOPENIA 2 0.0001
368 PULMONARY TOXICITY 1 0.0001
369 VISUAL FIELD DEFECT 1 0.0001
370 PRODUCT PRESCRIBING ISSUE 3 0.0001
371 LIVER FUNCTION TEST ABNORMAL 4 0.0001
372 C-REACTIVE PROTEIN INCREASED 5 0.0001
373 PSYCHIATRIC SYMPTOM 1 0.0001
374 BLOOD PRESSURE DECREASED 9 0.0001
375 BLOOD POTASSIUM DECREASED 4 0.0001
376 HEPATIC FAILURE 4 0.0001
377 PAROSMIA 1 0.0001
378 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
379 HAEMODYNAMIC INSTABILITY 1 0.0001
380 HYPERTHERMIA 1 0.0001
381 BOWEL MOVEMENT IRREGULARITY 1 0.0001
382 LIPASE INCREASED 1 0.0001
383 SHOCK 3 0.0001
384 CONCUSSION 1 0.0001
385 HYPOALBUMINAEMIA 1 0.0001
386 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
387 DRUG INTERACTION 20 0.0001
388 BLOOD ALBUMIN DECREASED 1 0.0001
389 SEPSIS 14 0.0001
390 ATRIAL FLUTTER 1 0.0001
391 PANCYTOPENIA 7 0.0001
392 METABOLIC ACIDOSIS 4 0.0001
393 STENT PLACEMENT 1 0.0001
394 INTERSTITIAL LUNG DISEASE 6 0.0001
395 POST PROCEDURAL INFECTION 1 0.0001
396 CEREBRAL INFARCTION 3 0.0001
397 LIVER INJURY 3 0.0001
398 HYPERAESTHESIA 1 0.0001
399 SPINAL COMPRESSION FRACTURE 1 0.0001
400 HEMIPLEGIA 1 0.0001
401 COAGULOPATHY 2 0.0001
402 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
403 VERTIGO 7 0.0001
404 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
405 URINE OUTPUT DECREASED 1 0.0001
406 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
407 VOMITING 53 0.0001
408 CARDIOTOXICITY 1 0.0001
409 PULMONARY OEDEMA 5 0.0001
410 JAUNDICE 3 0.0001
411 OEDEMA 6 0.0001
412 NEUTROPENIA 15 0.0001
413 ASTHENIA 41 0.0001
414 RESPIRATORY ARREST 3 0.0001
415 RESPIRATORY DISTRESS 3 0.0001
416 DIARRHOEA HAEMORRHAGIC 1 0.0001
417 HYPONATRAEMIA 6 0.0001
418 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
419 ACUTE RESPIRATORY FAILURE 2 0.0001
420 HYPERCHOLESTEROLAEMIA 1 0.0001
421 DIZZINESS POSTURAL 1 0.0001
422 NAUSEA 81 0.0001
423 RENAL TUBULAR NECROSIS 1 0.0001
424 LIGAMENT SPRAIN 1 0.0001
425 PRODUCT USE IN UNAPPROVED INDICATION 25 0.0001
426 BLOOD PRESSURE ABNORMAL 2 0.0001
427 RESPIRATORY DISORDER 3 0.0001
428 TASTE DISORDER 2 0.0001
429 BONE MARROW FAILURE 2 0.0001
430 NEUTROPHIL COUNT INCREASED 1 0.0001
431 PERITONITIS 2 0.0001
432 CARDIO-RESPIRATORY ARREST 4 0.0001
433 PRODUCT ODOUR ABNORMAL 1 0.0001
434 HYPOTENSION 19 0.0001
435 BRADYCARDIA 5 0.0001
436 DECREASED ACTIVITY 1 0.0001
437 ACNE 7 0.0001
438 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
439 BLOOD GLUCOSE FLUCTUATION 1 0.0001
440 FEBRILE NEUTROPENIA 6 0.0001
441 MALNUTRITION 1 0.0001
442 INTESTINAL PERFORATION 1 0.0001
443 MUSCULAR WEAKNESS 10 0.0001
444 IMPAIRED DRIVING ABILITY 1 0.0001
445 DERMATITIS CONTACT 1 0.0001
446 DECREASED APPETITE 20 0.0001
447 POST PROCEDURAL HAEMORRHAGE 1 0.0001
448 VASCULITIS 1 0.0001
449 PRODUCT DOSE OMISSION ISSUE 25 0.0001
450 COVID-19 PNEUMONIA 1 0.0001
451 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
452 DYSPHAGIA 8 0.0001
453 BLOOD IRON DECREASED 1 0.0001
454 BACTERAEMIA 1 0.0001
455 CHOLECYSTITIS 1 0.0001
456 DIZZINESS 41 0.0001
457 RESPIRATORY DEPRESSION 1 0.0001
458 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
459 GENERALISED OEDEMA 1 0.0001
460 ILEUS 1 0.0001
461 HEPATIC FUNCTION ABNORMAL 3 0.0001
462 HYPERTENSION 17 0.0001
463 DIABETES MELLITUS 6 0.0001
464 FLUID RETENTION 4 0.0001
465 MYDRIASIS 1 0.0001
466 INTENTIONAL OVERDOSE 5 0.0001
467 MUCOSAL INFLAMMATION 2 0.0001
468 ORAL CANDIDIASIS 1 0.0001
469 PULMONARY EMBOLISM 7 0.0001
470 IMPAIRED GASTRIC EMPTYING 1 0.0001
471 TREATMENT NONCOMPLIANCE 4 0.0001
472 PROCEDURAL PAIN 2 0.0001
473 ORAL DISCOMFORT 1 0.0001
474 RENAL IMPAIRMENT 6 0.0001
475 OXYGEN SATURATION DECREASED 4 0.0001
476 BLOOD TEST ABNORMAL 1 0.0001
477 SKIN REACTION 1 0.0001
478 SEASONAL ALLERGY 1 0.0001
479 SINUS TACHYCARDIA 1 0.0001
480 THERAPY INTERRUPTED 5 0.0001
481 CARDIOGENIC SHOCK 1 0.0001
482 APATHY 1 0.0001
483 FATIGUE 53 0.0001
484 FEELING HOT 4 0.0001
485 SOMNOLENCE 13 0.0001
486 BRAIN FOG 1 0.0001
487 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
488 HALLUCINATION, AUDITORY 1 0.0001
489 ABSCESS 1 0.0001
490 INFECTION 9 0.0001
491 PNEUMONIA 20 0.0001
492 LACTIC ACIDOSIS 2 0.0001
493 BLOOD CREATININE INCREASED 4 0.0001
494 MANIA 1 0.0001
495 DRUG LEVEL INCREASED 1 0.0001
496 RENAL FAILURE 8 0.0001
497 DEHYDRATION 8 0.0001
498 BLOOD UREA INCREASED 1 0.0001
499 FACE OEDEMA 1 0.0001
500 CANDIDA INFECTION 1 0.0001
501 CONDITION AGGRAVATED 18 0.0001
502 ACUTE KIDNEY INJURY 9 0.0001
503 CIRCULATORY COLLAPSE 1 0.0001
504 GASTRIC DISORDER 2 0.0001
505 PARANOIA 1 0.0001
506 BALANCE DISORDER 5 0.0001
507 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
508 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
509 ALOPECIA 11 0.0001
510 RESTLESS LEGS SYNDROME 1 0.0001
511 CONJUNCTIVITIS 1 0.0001
512 BACTERIAL INFECTION 1 0.0001
513 PRODUCT USE ISSUE 10 0.0001
514 DYSPNOEA EXERTIONAL 2 0.0001
515 BLOOD SODIUM DECREASED 1 0.0001
516 HYPOCALCAEMIA 1 0.0001
517 INCREASED APPETITE 1 0.0001
518 LETHARGY 3 0.0001
519 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
520 ATRIAL FIBRILLATION 5 0.0001
521 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
522 SURGERY 3 0.0001
523 DIARRHOEA 33 0.0001
524 MEMORY IMPAIRMENT 7 0.0001
525 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
526 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
527 ABNORMAL BEHAVIOUR 2 0.0001
528 DISORIENTATION 2 0.0001
529 HAEMATOCRIT DECREASED 1 0.0001
530 DRUG INEFFECTIVE 66 0.0001
531 ABORTION SPONTANEOUS 2 0.0000
532 SPINAL FRACTURE 1 0.0000
533 CARDIAC FAILURE 4 0.0000
534 FULL BLOOD COUNT DECREASED 1 0.0000
535 PRODUCT PHYSICAL ISSUE 1 0.0000
536 FEEDING DISORDER 1 0.0000
537 OSTEOPOROSIS 2 0.0000
538 RIB FRACTURE 1 0.0000
539 RHABDOMYOLYSIS 2 0.0000
540 HAEMORRHAGE 5 0.0000
541 WITHDRAWAL SYNDROME 2 0.0000
542 EATING DISORDER 1 0.0000
543 RETCHING 1 0.0000
544 LIVER FUNCTION TEST INCREASED 1 0.0000
545 PRURITUS GENERALISED 1 0.0000
546 VAGINAL HAEMORRHAGE 2 0.0000
547 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
548 MALAISE 20 0.0000
549 COVID-19 8 0.0000
550 HOSPITALISATION 7 0.0000
551 HEART RATE IRREGULAR 1 0.0000
552 DEATH 38 0.0000
553 PRODUCT AVAILABILITY ISSUE 1 0.0000
554 ADVERSE EVENT 4 0.0000
555 WEIGHT DECREASED 12 0.0000
556 TREMOR 7 0.0000
557 DISEASE RECURRENCE 2 0.0000
558 COMA 2 0.0000
559 BLOOD GLUCOSE DECREASED 2 0.0000
560 DYSPEPSIA 4 0.0000
561 PYREXIA 14 0.0000
562 AGEUSIA 1 0.0000
563 HYPOAESTHESIA 6 0.0000
564 PNEUMONIA ASPIRATION 1 0.0000
565 HOT FLUSH 3 0.0000
566 HAEMATEMESIS 1 0.0000
567 CARDIOVASCULAR DISORDER 1 0.0000
568 HYPOPHAGIA 1 0.0000
569 LOSS OF CONSCIOUSNESS 5 0.0000
570 DRUG RESISTANCE 1 0.0000
571 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
572 ABDOMINAL PAIN 9 0.0000
573 SKIN ULCER 1 0.0000
574 EAR INFECTION 1 0.0000
575 PLATELET COUNT DECREASED 4 0.0000
576 MENSTRUATION IRREGULAR 1 0.0000
577 CONFUSIONAL STATE 6 0.0000
578 DISTURBANCE IN ATTENTION 2 0.0000
579 LIMB INJURY 1 0.0000
580 PRODUCT QUALITY ISSUE 5 0.0000
581 PNEUMONITIS 1 0.0000
582 HEADACHE 23 0.0000
583 MOOD ALTERED 1 0.0000
584 CARDIAC ARREST 3 0.0000
585 HAEMOPTYSIS 1 0.0000
586 ABDOMINAL DISCOMFORT 6 0.0000
587 PAIN IN JAW 1 0.0000
588 FLATULENCE 2 0.0000
589 URINARY TRACT INFECTION 6 0.0000
590 ANGINA PECTORIS 1 0.0000
591 BACK PAIN 8 0.0000
592 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
593 ASCITES 1 0.0000
594 PSYCHOTIC DISORDER 1 0.0000
595 RENAL INJURY 1 0.0000
596 GASTROINTESTINAL DISORDER 3 0.0000
597 JOINT SWELLING 4 0.0000
598 THERAPEUTIC RESPONSE DECREASED 2 0.0000
599 SUICIDE ATTEMPT 2 0.0000
600 EPILEPSY 1 0.0000
601 HEAD INJURY 1 0.0000
602 HIP FRACTURE 1 0.0000
603 DRUG INTOLERANCE 3 0.0000
604 HYPERHIDROSIS 4 0.0000
605 STAPHYLOCOCCAL INFECTION 1 0.0000
606 FUNGAL INFECTION 1 0.0000
607 URINARY RETENTION 1 0.0000
608 TYPE 2 DIABETES MELLITUS 1 0.0000
609 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
610 FLUSHING 3 0.0000
611 HAEMOGLOBIN DECREASED 3 0.0000
612 ILLNESS 3 0.0000
613 DELIRIUM 1 0.0000
614 ABDOMINAL DISTENSION 3 0.0000
615 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
616 CEREBRAL HAEMORRHAGE 1 0.0000
617 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
618 MYELOSUPPRESSION 1 0.0000
619 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
620 CONSTIPATION 6 0.0000
621 AGITATION 2 0.0000
622 WEIGHT INCREASED 6 0.0000
623 DYSARTHRIA 1 0.0000
624 DYSPNOEA 15 0.0000
625 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
626 SEIZURE 3 0.0000
627 PARAESTHESIA 4 0.0000
628 PSORIATIC ARTHROPATHY 1 0.0000
629 ABDOMINAL PAIN UPPER 5 0.0000
630 RENAL FAILURE ACUTE 1 0.0000
631 ANGIOEDEMA 1 0.0000
632 TACHYCARDIA 2 0.0000
633 THROAT IRRITATION 1 0.0000
634 ADVERSE DRUG REACTION 2 0.0000
635 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
636 SKIN DISCOLOURATION 1 0.0000
637 BLOOD CHOLESTEROL INCREASED 1 0.0000
638 COGNITIVE DISORDER 1 0.0000
639 CARDIAC DISORDER 2 0.0000
640 SWELLING 2 0.0000
641 GAIT DISTURBANCE 4 0.0000
642 LUNG DISORDER 1 0.0000
643 HEART RATE INCREASED 2 0.0000
644 BLOOD PRESSURE INCREASED 3 0.0000
645 PAIN 12 0.0000
646 SPEECH DISORDER 1 0.0000
647 PANCREATITIS 1 0.0000
648 RASH PRURITIC 1 0.0000
649 TOXICITY TO VARIOUS AGENTS 3 0.0000
650 MYALGIA 3 0.0000
651 HERPES ZOSTER 1 0.0000
652 BONE PAIN 1 0.0000
653 WHEEZING 1 0.0000
654 CATARACT 1 0.0000
655 PLEURAL EFFUSION 1 0.0000
656 HYPERSENSITIVITY 3 0.0000
657 VISUAL IMPAIRMENT 2 0.0000
658 BLOOD GLUCOSE INCREASED 3 0.0000
659 INSOMNIA 4 0.0000
660 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
661 ARTHRALGIA 6 0.0000
662 BURNING SENSATION 1 0.0000
663 MOBILITY DECREASED 1 0.0000
664 UNDERDOSE 1 0.0000
665 PAIN IN EXTREMITY 4 0.0000
666 DEPRESSION 3 0.0000
667 CHRONIC KIDNEY DISEASE 1 0.0000
668 PERIPHERAL SWELLING 2 0.0000
669 FEELING ABNORMAL 3 0.0000
670 CARDIAC FAILURE CONGESTIVE 1 0.0000
671 PROSTATE CANCER 1 0.0000
672 THROMBOSIS 1 0.0000
673 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
674 INFLUENZA LIKE ILLNESS 1 0.0000
675 DRUG DOSE OMISSION 2 0.0000
676 FALL 4 0.0000
677 MUSCULOSKELETAL STIFFNESS 1 0.0000
678 NO ADVERSE EVENT 2 0.0000
679 MUSCLE SPASMS 2 0.0000
680 OROPHARYNGEAL PAIN 1 0.0000
681 BREAST CANCER 1 0.0000
682 CONTUSION 1 0.0000
683 SYNCOPE 1 0.0000
684 CHEST DISCOMFORT 1 0.0000
685 OVERDOSE 2 0.0000
686 INFLUENZA 1 0.0000
687 CHILLS 1 0.0000
688 VISION BLURRED 1 0.0000
689 COUGH 2 0.0000
690 ANXIETY 2 0.0000
691 URTICARIA 1 0.0000
692 CEREBROVASCULAR ACCIDENT 1 0.0000
693 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
694 INCORRECT DOSE ADMINISTERED 1 0.0000
695 PRURITUS 1 0.0000